Penn State commit Adam Breneman has found a way to use his fame for a good cause. Below, you can read the full press release from Catch the Cure, a campaign against ALS, organized by Adam and Project ALS.
ADAM BRENEMAN TEAMS UP WITH PROJECT A.L.S. TO CATCH THE CURE
Top-Ranked Tight End Joins Project A.L.S. to Raise Funds and Awareness for Deadly Neurodegenerative Disease
Camp Hill, PA—This fall, the nation’s top-ranked high school tight end is teaming up with Project A.L.S. to Catch the Cure—and stop the devastating brain disease ALS, also known as Lou Gehrig’s disease. Adam Breneman, who has committed to play football at Penn State in fall 2013, will dedicate his senior year at Cedar Cliff High School to raising money to cure ALS, a neurodegenerative illness that is closely related to Alzheimer’s and Parkinson’s.
Catch the Cure, marking the partnership between Breneman and Project A.L.S., will start a new chapter in ALS advocacy and fundraising. Breneman, whose talents have been extolled on ESPN, Bleacher Report, Scout.com and many other outlets, will work with Project A.L.S. to raise significant funds for ALS research, raise awareness about ALS and advocate for those with neurodegenerative brain diseases around the world.
“Adam is an incredibly talented and hardworking young man, but his empathy and drive to do good make him a truly exceptional person,” said Project A.L.S. President and Co-Founder Meredith Estess. “Project A.L.S. is honored to partner with him in the fight against ALS.”
ALS hit close to Breneman, 17, when his neighbor and brother’s former football coach Tom Kirchhoff was diagnosed. Breneman saw the devastating effect that the disease had on Kirchhoff, an executive at Cleveland Brothers, but he also saw Kirchhoff’s resilience and spirit. Kirchhoff, his family and friends, have refused to let ALS conquer them and instead proclaim, “We Will Win.” Cleveland Brothers has generously offered to match all funds raised in Catch the Cure to double its impact on ALS research.
Less than a month into planning the campaign, Breneman tore his ACL in a 7-on-7 scrimmage. Now, as he undergoes surgery and spends the year in rehab preparing to enter Penn State, he’s taken a lesson from Kirchhoff’s “We Will Win” mentality and is determined that his injury will make him mentally and physically stronger as a player. He will showcase his fight to recover and, supported by his community and teammates, will inspire people around the world to Catch the Cure for Project A.L.S. research.
“Tom and Adam are indomitable spirits. They personify the stubborn work in the face of adversity that will understand and effectively treat ALS,” said Meredith.
Every dollar raised through Catch the Cure will go directly to Project A.L.S. research. For more information about Adam and Catch the Cure:
Project A.L.S.™ is a non-profit 501©3 devoted to understanding, treating, and ultimately curing ALS, also known as Lou Gehrig’s disease. Founded in 1998 by Jenifer Estess, her family and friends, Project A.L.S. has become the new paradigm for brain disease research. ALS is a devastating neurodegenerative disease that, combined with the closely related Parkinson’s and Alzheimer’s diseases, is a 21st century epidemic. In ten years 1 in 25 Americans will be affected with a neurodegenerative disease. www.projectals.org.
ALS, also known as Lou Gehrig’s disease and motor neuron disease, is a fatal neurodegenerative disease that affects adults of all ages. It is closely related to Alzheimer’s, Parkinson’s, and Huntington’s. ALS targets large brain cells residing in the brain and along the spinal cord called motor neurons. In ALS, as motor neurons get sick and die, a person progressively loses the ability to move: to walk, speak, swallow, and breathe. ALS is usually fatal within 2-5 years of diagnosis.